Alterations in canonical PI3K/MAPK pathways are identified in more than 90% GBM samples [52, 66], and the most common and important gene alteration in this pathway is EGFR, whose amplification or mutation is identified in more than half (57%) of GBM samples [66]. The gene discussed is EGFR; the disease is glioblastoma.